RXO, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2023 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
RXO, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q1 2024.
- RXO, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$7M.
- RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$8M, a 60% increase from 2022.
- RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$20M, a 767% decline from 2021.
- RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $3M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)